Menopause Claims Back Under the Spotlight Following ASA Review
The UK Advertising Standards Authority (ASA) has flagged three menopause‑focused supplement brands—Lunera, Minerva Wellness and Nova—for making unauthorized health claims in paid social media ads. The advertisements suggested the products could treat menopause symptoms such as weight gain, hot flushes, joint pain and even restore estrogen, breaching CAP code rules and the GB Nutrition and Health Claims Register. Lunera voluntarily removed its ads and pledged tighter compliance, while the other two companies have not responded. The episode underscores growing regulatory scrutiny of women’s‑health marketing in Europe.
Oral Peptides Biotech Pinnacle Medicines Gets $89M From US, China Investors
Pinnacle Medicines, a two‑year‑old biotech focused on oral peptide therapeutics, secured $89 million from a mix of U.S. and Chinese investors. The financing will fund its platform that converts injectable peptides into pill form, building on the recent success of Novo...
6 Recommendations for PBM Procurement and Rx Benefits Optimization
The 2026 pharmacy benefit manager (PBM) RFP season is shaping up to be one of the most consequential for employers, driven by sweeping state and federal reforms and soaring healthcare costs. Nearly two‑thirds of plan sponsors are already considering alternatives...
Otsuka Pharmaceutical Reports P-III (VISIONARY) Trial Data on Voyxact for IgA Nephropathy (IgAN)
Otsuka Pharmaceutical presented Phase III VISIONARY trial data for Voyxact (sibeprenlimab‑szsi) in IgA nephropathy patients at risk of progression. At 48 weeks, 82.5% of patients receiving 400 mg subcutaneous Voyxact achieved negative microscopic hematuria versus 52.6% on placebo, with median time to...
International Menopause Society Sets New Global Standards for Menopause Care with Evidence-Led Framework
The International Menopause Society (IMS) has issued its first comprehensive overhaul of global menopause guidelines since 2016, delivering an evidence‑led framework developed by 38 experts and 27 contributors. The live, updateable document spans 30 sections covering symptoms, cardiometabolic health, bone...
India's Health Insurance Premiums Cross ₹1.2 Lakh Crore in 2024-25: Finance Ministry
India's health‑insurance premiums surged past ₹1.2 lakh crore (≈ $14.5 billion) in FY 2024‑25, marking a 9% year‑on‑year increase. The Insurance Regulatory and Development Authority of India (IRDAI) introduced tighter cashless claim timelines—one hour for pre‑authorisation and three hours for final approval—to speed...
Laudio and AONL Report Reveals Distinct Expectations and Work Patterns Among Gen Z in the Healthcare Workforce
The Laudio and AONL Spring 2026 report, based on a national dataset of nearly 100,000 RNs, shows Generation Z is the fastest‑growing nursing cohort and the only one still expanding. Gen Z nurses demand 2.5 times more frequent, meaningful manager interactions and...
The Doctor Behind One of Canada’s First MAID Deaths Speaks Out
In 2024 Canada recorded 16,499 medically assisted deaths, with Quebec responsible for more than a third of the total. The majority (99.99%) were active euthanasia cases using a three‑drug protocol, making MAID the fourth leading cause of death after cancer,...
Kallisio’s Stentra Receives CE Mark for Precision Oral Immobilization System in Head & Neck Radiation Therapy
Swiss‑based Kallisio has secured CE certification for its Stentra intraoral positioning system under the EU Medical Device Regulation 2017/745. The device, a patient‑specific 3‑D‑printed oral immobilizer, improves millimeter‑level accuracy in head‑and‑neck radiation therapy without altering existing treatment planning software or...
Cuban Doctors Endure Burnout, Blackouts as Once-Vaunted Healthcare Declines
Cuban doctors, earning roughly $16 a month, are forced to take side jobs to survive. The public health system faces severe shortages, with a surgery waiting list projected to swell to 160,000 by year‑end and over 300 pediatric operations each...
ER Boarding Raises Risk Of Poorer Patient Outcomes, Study Finds
A Johns Hopkins study of 173,168 admissions found that patients who board in emergency departments face a measurable risk of clinical deterioration. About 3.6% worsened within 48 hours, and nearly half of those events occurred while still in the ER....
An OB-GYN Was Repeatedly Accused of Sexual Misconduct. The State Medical Board Let Him Keep Practicing.
Washington’s medical commission allowed OB‑GYN Dr. Mark Mulholland to keep seeing patients despite at least four sexual‑misconduct complaints filed between 2022 and 2025. The complaints describe invasive pelvic exams, sexually charged language, and inappropriate touching. Although the commission issued formal...
Industry Fumes as Govt Plans to Beef up LHF Crackdown
The UK Department of Health & Social Care has opened a consultation to apply an updated Nutrient Profiling Model (NPM) to the existing less‑healthy food (LHF) advertising restrictions, extending the ban to a wider range of high‑sugar products such as...
How Hospital Administrators Can Unlock Growth with Digital Innovation
Hospital administrators are urged to adopt a digital‑first mindset to drive growth without adding complexity. By investing in online MHA education, leveraging data analytics, and automating routine tasks, they can improve efficiency, patient experience, and inter‑departmental communication. Secure, scalable platforms...
The Healing Power of Light: How Light Therapy Supports Wellness
Red and near‑infrared light therapy is gaining traction as a non‑invasive wellness tool, leveraging specific wavelengths to stimulate mitochondria and boost cellular ATP production. Clinical‑grade full‑body panels now bring deep‑tissue penetration into homes, promising consistent results for skin health, pain...
Asylum-Seeker Health Staff Gain Right to Work in NHS
From 26 March 2026 asylum‑seeking doctors, nurses and other qualified health professionals who have waited at least 12 months for an initial asylum decision will be allowed to work in any role listed on the Appendix Skilled Occupations at RQF level 6 or above,...
Biogen and Alteogen Partner for ALT-B4 to Advance Subcutaneous Formulations of Biologics
Biogen has signed an exclusive license with South Korean biotech Alteogen for ALT‑B4, a recombinant hyaluronidase enzyme that facilitates subcutaneous administration of biologics traditionally given intravenously. The agreement provides Alteogen with $20 million upfront, a $10 million payment upon initiation of a...
Heidi Launches a Mic for AI Scribe – Why?
Heidi has introduced the Heidi Remote, a 21‑gram wearable microphone that provides up to 14 hours of battery life for AI‑assisted clinical documentation. The device operates independently of phones or Wi‑Fi, capturing audio offline and syncing later, and is built...
What’s Next for Emergency Response Data in 2026?
In 2026 emergency response agencies will pivot from reactive tactics to data‑driven operations, leveraging predictive analytics, seamless interoperability, and community‑care models. Real‑time analytics will forecast demand spikes, enabling pre‑positioning of resources and faster response times. Integrated platforms will allow instant...
Probiotics Drink Reduces Loose Stools Tendency in Healthy Adults - Study
A randomized, double‑blind trial in Japan found that a daily 100 ml drink containing 10 billion CFU of Lactiplantibacillus plantarum 299v reduced bowel‑movement frequency and days with defecation in healthy adults prone to loose stools. After eight weeks, the probiotic group averaged 6.7...
CVS Health Partners with Google Cloud to Build AI-Driven Consumer Health Platform
CVS Health announced a strategic partnership with Google Cloud to launch Health100, an AI‑native consumer health platform that unifies patients, providers, payers and digital services. The platform leverages Google Gemini models, BigQuery and the Cloud Healthcare API to deliver an...
Beyond the Cornfields, Indiana’s Life Sciences Industry Grows Tall
Indiana’s life‑sciences sector is rapidly expanding, now encompassing over 3,300 companies that employ roughly 70,000 workers and generate a $102 billion economic impact. Flagship firms such as Eli Lilly are driving major investments, including a $13 billion Medicine Foundry slated to create 400...
Medications and Hypertrophic Cardiomyopathy: What To Avoid, What To Discuss
Patients diagnosed with hypertrophic cardiomyopathy (HCM) must scrutinize both prescription and over‑the‑counter drugs because certain classes can worsen obstruction or fluid balance. Vasodilators, ACE inhibitors, ARBs, nitrates, and dihydropyridine calcium‑channel blockers may increase heart stress in obstructive HCM, while non‑dihydropyridine...
Managing Endometriosis Pain
Managing endometriosis pain requires a personalized, multimodal approach that blends lifestyle changes, medical therapies, and, when needed, surgery. Dr. Megan Billow emphasizes tailoring treatment to individual symptoms, reproductive goals, and quality‑of‑life priorities. Options range from diet, regular exercise, NSAIDs, CBT,...
How U.S.A.I.D. Birth Control Meant for Africa Was Ruined
A Trump‑era memo reveals that roughly $9.7 million in contraceptives purchased by USAID for low‑income African nations became stranded in a Belgian warehouse after the agency was dismantled. By September 2025 only $1.6 million remained usable, while $8.1 million spoiled due to lack...
China’s Jiangsu Aidea Eyes Hong Kong Listing as Gateway to US and European Aids Markets
Jiangsu Aidea Pharmaceutical, a Shanghai‑Star Market listed firm specializing in HIV/AIDS therapies, is preparing a Hong Kong IPO to fund its expansion into the United States and Europe. The company projects the global AIDS‑treatment market to exceed $1.45 billion by 2027...
A Machine Learning Model May Enable Liver Cancer Risk Prediction with Routine Clinical Information
Researchers developed a random‑forest machine learning model that predicts hepatocellular carcinoma (HCC) risk using only routine clinical data—demographics, electronic health records, and standard blood tests. In a UK Biobank cohort the model achieved an AUROC of 0.88, and external validation...
Replacing TV Time with Reading or Desk Work May Lower Dementia Risk
A 19‑year Swedish cohort study of 20,811 adults aged 35‑64 found that mentally passive sedentary activities, such as TV watching, increase dementia risk, while mentally active sitting—reading or desk work—significantly lowers it. Substituting equal amounts of passive with active sedentary...
Cryoablation Outshines Radiation Therapy, Surgery for Treating Certain Lung Cancers
New research published in the Journal of Vascular and Interventional Radiology shows percutaneous cryoablation delivers high local control for medically inoperable stage IA non‑small cell lung cancer, especially tumors under 2 cm. In a single‑center analysis of 176 patients, one‑year and three‑year...
Temporary Workers in the NHS Need a Stronger Voice
A new National Guardian review finds that roughly two‑thirds of temporary NHS staff in England feel they have no voice, with fear of losing shifts the primary deterrent to speaking up. Ethnic minority temps report even higher levels of silence,...
Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript
Viatris Inc. outlined its long‑term growth outlook, emphasizing a balanced portfolio that spans low‑cost generics, established branded products, and a pipeline of innovative medicines. Management highlighted strategic investments in R&D, geographic expansion in emerging markets, and cost‑efficiency initiatives aimed at...
Hong Kong: Research and Tech Driving Life and Health Innovation
Hong Kong Science and Technology Parks Corporation convened leading life‑science firms, investors and partners at its CTC Marketplace to showcase the city’s emerging health‑tech ecosystem. The event highlighted Hong Kong’s strengths in translational research, clinical‑trial capacity and AI‑driven drug discovery,...
MHRA’s Tallon on the Tall Order of Boosting the U.K. as a Destination for Clinical Trials
Lawrence Tallon, the MHRA chief, is set to oversee the launch of the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 on April 28, 2026. The amendment represents the most extensive overhaul of U.K. clinical‑trial rules in two decades, targeting faster approval,...
Nursing Homes Fear Being Shortchanged in $1.5B Health Care Funding Split Amid Budget Negotiations
New York is considering a $1.5 billion health‑care funding increase that will be divided between hospitals and nursing homes, but the exact split remains uncertain. Nursing‑home operators are pressing for at least $750 million in Medicaid‑related support, arguing that current rates have...
CMS Considers New Ownership and Identity Verification Requirements for Medicare-Enrolled Providers and Suppliers
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information seeking feedback on proposed rules that would tighten ownership and identity verification for Medicare‑enrolled providers and suppliers. The agency is weighing a citizenship or permanent‑resident requirement for...
The Head Transplant Doctor Will See You Now
Italian neurosurgeon Sergio Canavero, famed for his controversial head‑transplant ambitions, claims a $100 million operation would require an 80‑person surgical team and could eventually give patients a new body. He cites early animal work—rat nerve‑fusion with polyethylene glycol, monkey and dog head...
Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products - 05/19/2026
The FDA’s Regulatory Education for Industry (REdI) Annual Conference will take place May 19‑20, 2026, offering both virtual and in‑person sessions at the White Oak Campus in Maryland. The two‑day program features three dedicated tracks—drugs, devices, and biologics—allowing participants to...
FDA Approves Avlayah as Treatment of Hunter Syndrome
Denali Therapeutics received accelerated FDA approval for Avlayon (tividenofusp alfa‑eknm), the first enzyme replacement therapy designed to cross the blood‑brain barrier for Hunter syndrome. The approval is based on a phase 1/2 trial of 47 boys up to 18 years, showing...
FY 2025 GDUFA Science and Research Report
The FDA’s Center for Drug Evaluation and Research released its FY 2025 GDUFA Science & Research Report, detailing more than 50 funded projects across eight priority scientific initiatives. The program targets bioequivalence, manufacturing standards, and advanced analytical methods to streamline abbreviated...
Patent Certifications and Suitability Petitions
Under the Hatch‑Waxman law, generic manufacturers must file a Paragraph IV certification asserting that a listed patent is invalid, unenforceable, or not infringed to obtain FDA approval. The first substantially complete ANDA with such a certification secures a 180‑day exclusivity period,...
This Cutting-Edge Treatment Hit the Rewind Button On Aging, Scientists Say
Researchers at Longeveron reported that a single infusion of laromestrocel, a mesenchymal stem‑cell therapy derived from donors aged 14‑18, significantly boosted mobility in frail seniors. In a double‑blind trial of about 150 participants aged 70‑85, the highest dose (200 million cells)...
Cardiologists Use Endovascular Device for Brain Aneurysms to Treat High-Risk Heart Patients
Mayo Clinic interventional cardiologists and radiologists have repurposed Terumo's WEB SLS II intrasaccular flow disruptor—originally approved for intracranial bifurcation aneurysms—to treat saccular coronary aneurysms. The first case involved a 74‑year‑old patient undergoing aortic valve replacement and bypass surgery, where the device achieved...
IRA Drug Provisions Linked to Significant Drop in Medicare Medication Nonadherence
New research shows the Inflation Reduction Act’s 2024 Medicare drug caps and expanded low‑income subsidies have materially reduced cost‑related medication nonadherence. A JAMA Internal Medicine study found a 4.9‑percentage‑point drop overall, rising to 7.8 points among beneficiaries with multiple chronic...
IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
The FDA announced new guidance that expands flexibility in chemistry, manufacturing, and controls (CMC) for cell and gene therapies (CGTs) across their development lifecycle. Sponsors can now defer full cGMP compliance until later trial phases and make iterative manufacturing changes...
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
The FDA granted accelerated approval to Avlayah (tividenofusp alfa‑eknm), a weekly IV infusion, for treating neurologic manifestations of Hunter syndrome in pediatric patients weighing at least 5 kg. The approval is based on a phase 1/2 trial that demonstrated a 91% average...
ACA Subsidy Cliffs Are Back and Costing Clients Thousands
For the first time in five years, the ACA’s enhanced premium tax credits expire at the end of 2025, restoring the pre‑pandemic subsidy structure. Households earning just above 400% of the federal poverty level—about $62,600 for an individual or $84,600...
Leveraging the Full Potential of Regenerative Medicine Requires a Proactive Approach
Regenerative medicine promises to shift healthcare from a reactive model to proactive disease modification by targeting early biological drivers of chronic degeneration. Cell‑based therapies such as mesenchymal stromal/stem cells (MSCs) can modulate inflammation, immune signaling, and tissue repair, showing benefits...